These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1224740)

  • 21. [Central nervous system complications in patients with cyanotic congenital heart diseases (author's transl)].
    Pernot C
    Chir Pediatr; 1980; 21(1):35-40. PubMed ID: 7408065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of coagulation factors in cyanotic children with congenital heart defects].
    Goldschmidt B
    Ann Paediatr; 1966; 207(5):321-8. PubMed ID: 6012677
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of sufficient hemodilution to prevent coagulopathies following surgical correction of cyanotic heart disease.
    Milam JD; Austin SF; Nihill MR; Keats AS; Cooley DA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):623-9. PubMed ID: 3982066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The platelets in cyanotic congenital heart disease.
    Gross S; Keefer V; Liebman J
    Pediatrics; 1968 Oct; 42(4):651-8. PubMed ID: 5681283
    [No Abstract]   [Full Text] [Related]  

  • 26. Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease.
    Gralnick HR
    Lancet; 1970 Jun; 1(7658):1204-5. PubMed ID: 4192381
    [No Abstract]   [Full Text] [Related]  

  • 27. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
    Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
    Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of lowering the hematocrit on polycythemia and thrombocytopenia in congenital cyanotic heart defect].
    de Haan M; de Koning J; Ottenkamp J; Schilte PP
    Tijdschr Kindergeneeskd; 1985 Oct; 53(5):178-81. PubMed ID: 2418530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation abnormalities in patients with cyanotic congenital heart disease.
    Tempe DK; Virmani S
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):752-65. PubMed ID: 12486661
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebrovascular accidents in infants and children with congenital cyanotic heart disease.
    Amitai Y; Blieden L; Shemtov A; Neufeld H
    Isr J Med Sci; 1984 Dec; 20(12):1143-5. PubMed ID: 6519944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinogen metabolism in cyanoti congenital heart disease.
    Goldschmidt B; Siegler J; Schmidt M
    Haematologia (Budap); 1977; 11(1-2):169-76. PubMed ID: 615088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated intravascular coagulation in children.
    Lascari AD
    J Iowa Med Soc; 1971 Nov; 61(11):676-82. PubMed ID: 5115184
    [No Abstract]   [Full Text] [Related]  

  • 33. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
    Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprotinin in open-heart surgery of infants and children using the heart-lung machine.
    Urban AE; Popov-Cenić S; Noë G; Kulzer R
    Clin Ther; 1984; 6(4):425-33. PubMed ID: 6205754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
    Broberg CS; Bax BE; Okonko DO; Rampling MW; Bayne S; Harries C; Davidson SJ; Uebing A; Khan AA; Thein S; Gibbs JS; Burman J; Gatzoulis MA
    J Am Coll Cardiol; 2006 Jul; 48(2):356-65. PubMed ID: 16843187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood coagulation studies and extracorporeal circulation in man.
    Thurnherr N
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):634-46. PubMed ID: 5590250
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy of preoperative administration of a single dose of recombinant human erythropoietin in pediatric cardiac surgery.
    Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T
    Heart Surg Forum; 2007; 10(2):E115-9. PubMed ID: 17597033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Data on the behavior of hemopexin in acute leukemia in childhood in relation to the blood coagulation picture].
    Esposito L; di Gennaro C
    Pediatria (Napoli); 1977 Mar; 85(1):12-20. PubMed ID: 267268
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the coagulation system in children with two-ventricle congenital heart disease.
    Odegard KC; Zurakowski D; Hornykewycz S; DiNardo JA; Castro RA; Neufeld EJ; Laussen PC
    Ann Thorac Surg; 2007 May; 83(5):1797-803. PubMed ID: 17462402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.